ZERO WINTERDEAL 2025: Bis zu 300 € Prämie + Gratis-Aktie + finanzen.net MSCI World-ETF - Jetzt informieren!

Will Universal Health Services (UHS) Beat Estimates Again in Its Next Earnings Report?

24.10.25 18:10 Uhr

Werte in diesem Artikel
Aktien

179,00 EUR -2,00 EUR -1,10%

Indizes

1.854,4 PKT -8,4 PKT -0,45%

6.791,7 PKT 53,3 PKT 0,79%

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Universal Health Services (UHS), which belongs to the Zacks Medical - Hospital industry, could be a great candidate to consider.This hospital and health facility operator has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 10.66%.For the most recent quarter, Universal Health Services was expected to post earnings of $4.85 per share, but it reported $5.35 per share instead, representing a surprise of 10.31%. For the previous quarter, the consensus estimate was $4.36 per share, while it actually produced $4.84 per share, a surprise of 11.01%.Price and EPS SurpriseThanks in part to this history, there has been a favorable change in earnings estimates for Universal Health Services lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.Universal Health Services currently has an Earnings ESP of +4.80%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #2 (Buy) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on October 27, 2025.With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Universal Health Services, Inc. (UHS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Universal Health Services und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Universal Health Services

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Universal Health Services

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Universal Health Services Inc.

Wer­bung

Analysen zu Universal Health Services Inc.

DatumRatingAnalyst
03.01.2019Universal Health Services BuyDeutsche Bank AG
20.10.2017Universal Health Services OutperformBMO Capital Markets
27.04.2017Universal Health Services OutperformRBC Capital Markets
05.04.2017Universal Health Services BuyDeutsche Bank AG
27.03.2017Universal Health Services BuyMizuho
DatumRatingAnalyst
03.01.2019Universal Health Services BuyDeutsche Bank AG
20.10.2017Universal Health Services OutperformBMO Capital Markets
27.04.2017Universal Health Services OutperformRBC Capital Markets
05.04.2017Universal Health Services BuyDeutsche Bank AG
27.03.2017Universal Health Services BuyMizuho
DatumRatingAnalyst
27.02.2017Universal Health Services NeutralMizuho
09.11.2016Universal Health Services NeutralMizuho
21.04.2016Universal Health Services HoldStandpoint Research
29.10.2015Universal Health Services Equal WeightBarclays Capital
03.08.2015Universal Health Services Equal WeightBarclays Capital

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Universal Health Services Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen